Kevin Czerney - Jan 10, 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
VP, Chief Accounting Officer
Signature
s/ Dane Baumgardner, Attorney-In-Fact for Kevin Czerney
Stock symbol
XRAY
Transactions as of
Jan 10, 2025
Transactions value $
$353
Form type
4
Date filed
1/14/2025, 04:56 PM
Previous filing
Nov 12, 2024
Next filing
Mar 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +101 +0.56% $0.00 18.2K Jan 10, 2025 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Phantom Stock (Dentsply Supplemental Savings Plan) DSSP Award $51.60 +2.79 +0.86% $18.51 325 Jan 10, 2025 Common Stock 2.79 Direct F4, F5
transaction XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Award $302 +16.3 +0.86% $18.51 1.9K Jan 10, 2025 Common Stock 16.3 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2 Includes 309 shares acquired between July 1st - December 31, 2024 under the Dentsply Sirona Employee Stock Purchase Plan.
F3 Includes 50.706 shares acquired through dividend reinvestment on 1/10/2025.
F4 Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
F5 Comprised of phantom stock acquired as a result of accrued dividends.